Target Volume Definition in Non-Small Cell Lung Cancer

Proper target volume delineation is a crucial stage of treatment planning, so any error introduced in this process is a systematic error and cannot be quantified and/or detected by modern treatment technologies, unlike other sources of geometrical uncertainties. All steps of target definition should be standardized. In non-small cell lung cancer radiotherapy, there are specific problems related to the definition of all three consecutive target volumes recommended by ICRU: gross tumor volume (GTV), clinical target volume (CTV), and planning target volume (PTV). In GTV delineation, the proper imaging, e.g., standardized way of the use of CT and PET-CT, and continuous radiological training of radiation oncologists are emphasized. For CTV, we still lack robust data on the margin which is necessary to expand around GTV of the tumor and pathologic lymph nodes to adequately account for microscopic spread. Additionally, elective nodal irradiation is still a source of controversies. For PTV definition, major increase in technologies is involved. It leads in some cases to improvement of the tumor coverage and sparing of organs at risk, but as this process is expensive and time consuming, it might not be always beneficial.

[1]  Liesbeth Boersma,et al.  Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors. , 2007, International journal of radiation oncology, biology, physics.

[2]  P. Remeijer,et al.  Set-up verification using portal imaging; review of current clinical practice. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  André Wambersie,et al.  The International Commission on Radiation Units and Measurements , 2001, Journal of the ICRU.

[4]  Nandita Mitra,et al.  Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Jinming Yu,et al.  Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[6]  K. Bujko,et al.  Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study. , 2011, International journal of radiation oncology, biology, physics.

[7]  Di Yan,et al.  Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. , 2003, International journal of radiation oncology, biology, physics.

[8]  Bernard Dubray,et al.  Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  T. Uematsu,et al.  Treatment of roentgenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low-dose-rate brachytherapy: second report. , 2000, International journal of radiation oncology, biology, physics.

[10]  C. Williams,et al.  Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review , 2001, Thorax.

[11]  Suresh Senan,et al.  European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Michael K Gould,et al.  Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). , 2007, Chest.

[13]  M. V. van Herk,et al.  The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[14]  T. Rice,et al.  Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort. , 2008, International journal of radiation oncology, biology, physics.

[15]  Hak Choy,et al.  A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515. , 2009, International journal of radiation oncology, biology, physics.

[16]  Jan-Jakob Sonke,et al.  Adaptive radiotherapy for lung cancer. , 2010, Seminars in radiation oncology.

[17]  S. Kudoh,et al.  Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  T. Naruke,et al.  Lymph node mapping and curability at various levels of metastasis in resected lung cancer. , 1978, The Journal of thoracic and cardiovascular surgery.

[19]  S. Davies,et al.  Big brother : Britain's web of surveillance and the new technological order , 1996 .

[20]  Hisao Asamura,et al.  The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  C. Mountain,et al.  Regional lymph node classification for lung cancer staging. , 1997, Chest.

[22]  Ursula Nestle,et al.  Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  S. Sak,et al.  Changing patterns of lung cancer; (3/4 in.) 1.9 cm; still a safe length for bronchial resection margin? , 2000, Lung cancer.

[24]  I. Park,et al.  Long-term survival following pneumonectomy for non-small cell lung cancer: clinical implications for follow-up care. , 2007, Chest.

[25]  D. Yan,et al.  Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[26]  J C Rosenwald,et al.  Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. , 2000, International journal of radiation oncology, biology, physics.

[27]  N. Willich,et al.  Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. , 2008, The Lancet. Oncology.

[28]  Giuseppe Lucio Cascini,et al.  Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC). , 2007, Lung cancer.

[29]  Tomio Inoue,et al.  Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  D. de Ruysscher,et al.  Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study. , 2010, International journal of radiation oncology, biology, physics.

[31]  J. Battista,et al.  Radiation treatment of lung cancer--patterns of practice in Canada. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  Designing targets for elective nodal irradiation in lung cancer radiotherapy: a planning study. , 2009, International journal of radiation oncology, biology, physics.

[33]  Suresh Senan,et al.  4D imaging for target definition in stereotactic radiotherapy for lung cancer , 2006, Acta oncologica.

[34]  Jinming Yu,et al.  A Randomized Study of Involved-Field Irradiation Versus Elective Nodal Irradiation in Combination With Concurrent Chemotherapy for Inoperable Stage III Nonsmall Cell Lung Cancer , 2007, American journal of clinical oncology.

[35]  Marcel van Herk,et al.  Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  Jan-Jakob Sonke,et al.  Kilo-voltage cone-beam computed tomography setup measurements for lung cancer patients; first clinical results and comparison with electronic portal-imaging device. , 2007, International journal of radiation oncology, biology, physics.

[37]  Otto S Hoekstra,et al.  The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[38]  B. Jeremic,et al.  Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC). , 2008, International journal of radiation oncology, biology, physics.

[39]  Otto S Hoekstra,et al.  Detection and Staging of Preinvasive Lesions and Occult Lung Cancer in the Central Airways with 18F-Fluorodeoxyglucose Positron Emission Tomography: A Pilot Study , 2005, Clinical Cancer Research.

[40]  R. Fisher,et al.  Measurement of lung tumor volumes using three-dimensional computer planning software. , 2002, International journal of radiation oncology, biology, physics.

[41]  K. Bujko,et al.  Dose-per-Fraction Escalation of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy in Locally Advanced Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[42]  K. Bujko,et al.  Cardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[43]  Carsten Brink,et al.  Deviations in delineated GTV caused by artefacts in 4DCT. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  S. Sak,et al.  Proximal bronchial extension with special reference to tumor localization in non-small cell lung cancer. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[45]  W. Oyen,et al.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[46]  S. Senan,et al.  What margins are necessary for incorporating mediastinal nodal mobility into involved-field radiotherapy for lung cancer? , 2002, International journal of radiation oncology, biology, physics.

[47]  S. Lehnert,et al.  Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box? , 2010, International journal of radiation oncology, biology, physics.

[48]  S. Sak,et al.  Prognostic implications of microscopic proximal bronchial extension in non-small cell lung cancer. , 2002, The Annals of thoracic surgery.

[49]  P. Voet,et al.  Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer (NSCLC)? , 2002, Lung cancer.

[50]  Liesbeth Boersma,et al.  Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features. , 2012, International journal of radiation oncology, biology, physics.

[51]  Lawrence B Marks,et al.  Elective nodal irradiation for locally advanced non-small-cell lung cancer: it's called cancer for a reason. , 2009, International journal of radiation oncology, biology, physics.

[52]  Suresh Senan,et al.  Tumor location cannot predict the mobility of lung tumors: a 3D analysis of data generated from multiple CT scans. , 2003, International journal of radiation oncology, biology, physics.

[53]  J. Daurès,et al.  Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  Eike Rietzel,et al.  Design of 4D treatment planning target volumes. , 2006, International journal of radiation oncology, biology, physics.

[55]  R. Arriagada,et al.  Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. , 1991, Journal of the National Cancer Institute.

[56]  W. Curran,et al.  Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer : Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group , 2000 .

[57]  Di Yan,et al.  Defining a radiotherapy target with positron emission tomography. , 2002, International journal of radiation oncology, biology, physics.

[58]  J. Herndon,et al.  Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. , 1996, Journal of the National Cancer Institute.

[59]  K. Bujko,et al.  Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques – A retrospective analysis , 2008, Acta oncologica.

[60]  R. Rami-Porta,et al.  Complete resection in lung cancer surgery: proposed definition. , 2005, Lung cancer.

[61]  Marcel van Herk,et al.  Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. , 2006, International Journal of Radiation Oncology, Biology, Physics.

[62]  G. Giaccone,et al.  Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). , 2007, European journal of cancer.

[63]  Lucyna Kepka,et al.  Delineation variation of lymph node stations for treatment planning in lung cancer radiotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[64]  Ladislav Pecen,et al.  Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. , 2004, Lung cancer.

[65]  Arjan Bel,et al.  Definition of gross tumor volume in lung cancer: inter-observer variability. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[66]  Eike Rietzel,et al.  Maximum-intensity volumes for fast contouring of lung tumors including respiratory motion in 4DCT planning. , 2008, International journal of radiation oncology, biology, physics.

[67]  Randall K Ten Haken,et al.  CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. , 2005, International journal of radiation oncology, biology, physics.

[68]  K. Rosenzweig,et al.  Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy? , 2006, International journal of radiation oncology, biology, physics.

[69]  D. Galetta,et al.  Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[70]  P. Lambin,et al.  HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[71]  Icru Prescribing, recording, and reporting photon beam therapy , 1993 .

[72]  Jan-Jakob Sonke,et al.  Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. , 2006, International journal of radiation oncology, biology, physics.

[73]  K. Ulm,et al.  Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  S. Burdett,et al.  Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.

[75]  J. Herndon,et al.  Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  M. Tsao,et al.  PET CT thresholds for radiotherapy target definition in non-small-cell lung cancer: how close are we to the pathologic findings? , 2010, International journal of radiation oncology, biology, physics.